Black Rock Inc. Werewolf Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,587,724 shares of HOWL stock, worth $3.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,587,724

Previous 164,792 863.47%

Holding current value

$3.25 Million

Previous $1.07 Million 263.07%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.34 - $6.75 $3.33 Million - $9.6 Million	1,422,932 Added 863.47%	1,587,724 $3.87 Million
Q1 2024 May 10, 2024	BUY	$3.92 - $7.91 $362,850 - $732,181	92,564 Added 128.16%	164,792 $1.07 Million
Q4 2023 Feb 13, 2024	SELL	$1.78 - $4.15 $8,695 - $20,272	-4,885 Reduced 6.33%	72,228 $278,000
Q3 2023 Nov 13, 2023	BUY	$2.0 - $3.82 $6,264 - $11,964	3,132 Added 4.23%	77,113 $165,000
Q2 2023 Aug 11, 2023	BUY	$2.31 - $3.65 $80,819 - $127,702	34,987 Added 89.72%	73,981 $225,000
Q1 2023 May 12, 2023	BUY	$1.98 - $4.3 $902 - $1,960	456 Added 1.18%	38,994 $101,000
Q4 2022 Feb 13, 2023	SELL	$1.53 - $4.73 $167,490 - $517,797	-109,471 Reduced 73.96%	38,538 $79,000
Q3 2022 Nov 14, 2022	SELL	$4.14 - $7.42 $148,824 - $266,734	-35,948 Reduced 19.54%	148,009 $668,000
Q2 2022 Aug 12, 2022	SELL	$3.43 - $5.98 $3.77 Million - $6.58 Million	-1,099,588 Reduced 85.67%	183,957 $752,000
Q1 2022 May 12, 2022	BUY	$3.71 - $12.22 $27,220 - $89,658	7,337 Added 0.57%	1,283,545 $5.65 Million
Q4 2021 Feb 10, 2022	BUY	$11.48 - $17.65 $10.4 Million - $16 Million	906,247 Added 244.96%	1,276,208 $15.2 Million
Q3 2021 Nov 09, 2021	BUY	$13.89 - $20.31 $56,921 - $83,230	4,098 Added 1.12%	369,961 $6.35 Million
Q2 2021 Aug 11, 2021	BUY	$11.6 - $17.44 $4.24 Million - $6.38 Million	365,863 New	365,863 $6.38 Million

Others Institutions Holding HOWL

# of Institutions

Shares Held

32.3M

Call Options Held

53.8K

Put Options Held

1.3K

View Full List

About Werewolf Therapeutics, Inc.

Ticker HOWL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,529,400
Market Cap $60.5M
Description
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...

More about HOWL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account